Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a causative agent of the CoV disease 2019 (COVID-19) pandemic, enters host cells via the interaction of its receptor-binding domain (RBD) of the spike protein with host angiotensin-converting enzyme 2 (ACE2). Therefore, the RBD is a promising vaccine target to induce protective immunity against SARS-CoV-2 infection.
Article activity feed
-
-
SciScore for 10.1101/2021.01.28.428743: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: All animal cares were performed strictly following the animal care guideline and experiment protocols approved by the Institutional Animal Care and Use Committee (IACUC) in Chungbuk National University Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Animal Care: Male and female ferrets of 16-20 months old and tested seronegative for Influenza A, MERS-CoV, and SARS-CoV were purchased from ID Bio Corporation (Cheongju, Korea). Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Expression and purification of nanoparticles: HEK293T cells were directly … SciScore for 10.1101/2021.01.28.428743: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: All animal cares were performed strictly following the animal care guideline and experiment protocols approved by the Institutional Animal Care and Use Committee (IACUC) in Chungbuk National University Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Animal Care: Male and female ferrets of 16-20 months old and tested seronegative for Influenza A, MERS-CoV, and SARS-CoV were purchased from ID Bio Corporation (Cheongju, Korea). Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Expression and purification of nanoparticles: HEK293T cells were directly purchased from American Type Culture Collection (ATCC) and maintained in DMEM medium (Gibco) supplemented with 10% FBS (Gibco) and 1% penicillin/streptomycin (Gibco). HEK293Tsuggested: NoneInfectious viruses from the nasal washes and lung tissues were quantified by inoculation onto Vero cells. Verosuggested: CLS Cat# 605372/p622_VERO, RRID:CVCL_0059)Software and Algorithms Sentences Resources Computer-assisted three-dimensional model of nanoparticles: Previously solved structures of H. pylori ferritin nanoparticle (PDB: 3EGM) and SARS-CoV-2 RBD (PDB: 7JMP) were processed with PyMol (Schrodinger) and Autodesk Meshmixer (Autodesk). PyMolsuggested: (PyMOL, RRID:SCR_000305)Statistical Analysis: All figure asterisks indicate statistical significance compared with adjuvant-only group as evaluated by the two-way ANOVA Dunnett’s multiple comparisons tests (* indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001 and **** indicates p<0.0001) and were drawn using GraphPad Prism 8 (GraphPad). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- No conflict of interest statement was detected. If there are no conflicts, we encourage authors to explicit state so.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
